Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Ddf Parallel Llp investment portfolio
Ddf Parallel Llp has made numerous investments in companies such as Amphista Therapeutics, Astronautx, and Loqus23 Therapeutics within the Biotech sector.
unknown
Portfolio
3
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (3)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Amphista Therapeutics Limited AMPHISTA THERAPEUTICS LIMITED is a biopharmaceutical company that develops next-generation targeted protein degradation (TPD) therapeutics. They utilize their proprietary Targeted Glue® technology to selectively degrade and remove disease-causing proteins. Their focus is on developing treatments for a range of severe diseases, including oncology, neurodegenerative diseases, immunology, and inflammatory disorders. | Healthcare & Life Sciences | Confirmed | 2025-12-06 |
| Astronautx Limited | Healthcare & Life Sciences | Confirmed | 2026-03-31 |
Shareholding changes (4)
Ddf Parallel Llp's positions across portfolio companies2025
- SERIES B PREFERRED 116,368 → 157,894
- SERIES A-1 PREFERRED SHARES 195,000 → 0
- SERIES A-2 PREFERRED 72,406 → 187,406
- SERIES A-1 PREFERRED 0 → 195,000
Articles (1)
- Loqus23 Therapeutics secures £15m funding for neurodegenerative disease research3 Jun 2026Loqus23 Therapeutics